Japanese Researchers Investigate Intracranial Hemorrhage Deaths Possibly Caused by Pfizer’s COVID-19 Vaccine

Japanese Researchers Investigate Intracranial Hemorrhage Deaths Possibly Caused by Pfizer’s COVID-19 Vaccine

A clinical pharmacology and medical informatics professional from two Japanese universities recently analyzed potential adverse events associated with the COVID-19 mRNA-based vaccine called tozinameran—the Pfizer-BioNTech vaccine known as BNT162b2. The Japanese report indicates that reports of cerebral venous sinus thrombosis and intracranial hemorrhage (ICH) after receiving COVID-19 vaccination point to concerns involving safety. Rumiko Shimazawa, with the Department of Clinical Pharmacology, Tokai University School of Medicine and Masayuki Ikeda, Department of Medical Informatics, Kagawa University Hospital, Miki-Cho, Kagawa, shared that presently no regulatory authority recognizes ICH as an adverse event associated with BNT162b2. But they share that in Japan, fatal and non-fatal cases are known. For example, in Japan, ten people have died in association with this vaccine. The dead included both five men and five women. Of note, four of the five women died of ICH, and the other died of aspiration pneumonia. Apparently, all five of the males died due to causes other than a stroke.

Shimazawa and Ikeda write that “Cumulatively…a disproportionately high incidence o...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee